Irbesartan and Peritonitis - a phase IV clinical study of FDA data

Summary:

Peritonitis is reported as a side effect among people who take Irbesartan (irbesartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Ventolin, and have Schizophrenia.

The phase IV clinical study analyzes which people have Peritonitis when taking Irbesartan. It is created by eHealthMe based on reports of 35,908 people who have side effects when taking Irbesartan from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Peritonitis?

Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs) is found to be associated with 1,062 drugs and 1,569 conditions by eHealthMe. Check the latest studies of Peritonitis.

On Jul, 14, 2026

35,908 people reported to have side effects when taking Irbesartan.
Among them, 64 people (0.18%) have Peritonitis.

Among these 64 people:

How long have people been on Irbesartan when they have Peritonitis? *

What is the gender of people who have Peritonitis when taking Irbesartan? *

female: 71.19 %
male: 28.81 %

What is the age of people who have Peritonitis when taking Irbesartan? *

What are other drugs people take besides Irbesartan? *

Clozaril: 26 people, 40.62%
Ventolin: 26 people, 40.62%
Metformin: 25 people, 39.06%
Aspirin: 16 people, 25.00%
Omeprazole: 12 people, 18.75%
Pioglitazone: 11 people, 17.19%
Trihexyphenidyl Hydrochloride: 11 people, 17.19%
Aripiprazole: 11 people, 17.19%
Amlodipine: 7 people, 10.94%
Extraneal: 6 people, 9.38%

What are other side effects people have besides Peritonitis? *

Gastric Disorder (disease of stomach): 29 people, 45.31%
Haematemesis (vomiting of blood): 28 people, 43.75%
Constipation: 28 people, 43.75%
Diverticular Perforation (serious gastrointestinal condition in which the intestine's walls are perforated): 27 people, 42.19%
Salivary Hypersecretion (excess saliva secretion): 26 people, 40.62%
Unresponsive To Stimuli: 25 people, 39.06%
Acute Kidney Failure: 6 people, 9.38%
Nausea And Vomiting: 5 people, 7.81%
Device Related Infection: 5 people, 7.81%
Renal Impairment (severely reduced kidney function): 5 people, 7.81%

What are the existing conditions these people have? *

Type 2 Diabetes: 26 people, 40.62%
Salivary Hypersecretion (excess saliva secretion): 26 people, 40.62%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 26 people, 40.62%
Constipation: 26 people, 40.62%
High Blood Cholesterol: 26 people, 40.62%
Abdominal Discomfort: 26 people, 40.62%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 26 people, 40.62%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 6.25%
Nephropathy (damage to or disease of a kidney): 3 people, 4.69%
Diabetes: 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and have Peritonitis?

- Check whether Peritonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Irbesartan:

Irbesartan (36,414 reports)

Peritonitis treatments and more:

Peritonitis (27,277 reports)

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peritonitis:

Peritonitis (1,062 drugs)

Browse all the conditions that are associated with Peritonitis:

Peritonitis (1,569 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Irbesartan) and Irbesartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.